Product Images Pentoxifylline
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 3 images provide visual information about the product associated with Pentoxifylline NDC 16571-856 by Rising Pharma Holdings, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
pentoxifyllinelabel - pentoxifyllinelabel
This text provides details about Pentoxifylline Extended-Release Tablets, USP, with a strength of 400 mg and a quantity of 500 tablets. The usual dosage recommends one tablet three times a day with meals. It advises storing the medication in a tight light-resistant container, at a temperature between 20° to 25°C, protected from light. The manufacturer is Rising Pharma Holdings, Inc, and the product is made in India. Additionally, it includes a code number, issuance date, and a reference number LR85650-00 for tracking purposes.*
pentoxifyllinestruct - pentoxifyllinestruct
pentoxifyllinetable - pentoxifyllinetable
This text provides a detailed breakdown of the side effects experienced by patients participating in clinical trials involving the use of extended-release tablets and immediate-release capsules of Pentoxifylline and Placebo. The data categorizes the side effects by body system, such as cardiovascular, digestive, and nervous systems, listing symptoms like chest pain, palpitations, abdominal discomfort, bloating, dizziness, headache, insomnia, and blurred vision among others. This information is valuable for healthcare professionals and researchers evaluating the safety and tolerability of these medications.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
